Revance Therapeutics Net Income 2012-2020 | RVNC

Revance Therapeutics net income from 2012 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Revance Therapeutics Annual Net Income
(Millions of US $)
2019 $-159
2018 $-143
2017 $-121
2016 $-89
2015 $-73
2014 $-63
2013 $0
2012 $-58
2011 $-45
Revance Therapeutics Quarterly Net Income
(Millions of US $)
2020-09-30 $-81
2020-06-30 $-61
2020-03-31 $-62
2019-12-31 $-45
2019-09-30 $-41
2019-06-30 $-37
2019-03-31 $-35
2018-12-31 $-41
2018-09-30 $-33
2018-06-30 $-34
2018-03-31 $-35
2017-12-31 $-36
2017-09-30 $-31
2017-06-30 $-27
2017-03-31 $-27
2016-12-31 $-27
2016-09-30 $-18
2016-06-30 $-25
2016-03-31 $-20
2015-12-31 $-22
2015-09-30 $-19
2015-06-30 $-17
2015-03-31 $-15
2014-12-31 $-14
2014-09-30 $-14
2014-06-30 $-13
2014-03-31 $-21
2013-12-31 $-14
2013-09-30 $-13
2013-06-30 $-16
2013-03-31 $5
2012-12-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.842B $0.015B
Revance is a Silicon Valley-based biotechnology company. The company is developing a portfolio of products for aesthetic medicine and underserved therapeutic specialties, including dermatology and neurology. Revance's science is based upon a proprietary TransMTS? peptide technology, which when combined with active drug molecules, may help address current unmet needs. Revance's initial focus is on developing daxibotulinumtoxinA, the company's highly purified botulinum toxin, for a broad spectrum of aesthetic and therapeutic indications, including facial wrinkles and muscle movement disorders. The company's lead drug candidate, DaxibotulinumtoxinA for Injection (RT002), is currently in development for the treatment of glabellar lines and cervical dystonia and has the potential to be the first long-acting neurotoxin. The company holds worldwide rights for all indications of RT002 injectable and RT001 topical and the pharmaceutical uses of the TransMTS technology platform.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $136.109B 9.43
Amgen (AMGN) United States $129.340B 13.49
CSL (CSLLY) Australia $93.980B 0.00
Gilead Sciences (GILD) United States $78.851B 8.85
Illumina (ILMN) United States $60.754B 92.54
Vertex Pharmaceuticals (VRTX) United States $54.186B 23.03
Moderna (MRNA) United States $52.458B 0.00
Regeneron Pharmaceuticals (REGN) United States $47.859B 15.64
Biogen (BIIB) United States $40.613B 8.12
Alexion Pharmaceuticals (ALXN) United States $32.579B 12.69
BeiGene (BGNE) Cayman Islands $27.859B 0.00
Seagen (SGEN) United States $26.800B 45.94
BioNTech SE (BNTX) Germany $23.416B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $22.659B 0.00
Exact Sciences (EXAS) United States $21.402B 0.00
Genmab (GMAB) Denmark $21.335B 29.86
Horizon Therapeutics Public (HZNP) Ireland $20.391B 23.40
Genmab (GNMSF) Denmark $19.992B 4.74
Bio-Rad Laboratories (BIO.B) United States $17.927B 57.05
Alnylam Pharmaceuticals (ALNY) United States $16.886B 0.00
Incyte (INCY) United States $16.713B 0.00
ARGENX SE-ADR (ARGX) Netherlands $14.971B 0.00
Guardant Health (GH) United States $14.431B 0.00
Bio-Techne Corp (TECH) United States $14.016B 80.28
BioMarin Pharmaceutical (BMRN) United States $13.835B 110.28
Novavax (NVAX) United States $13.561B 0.00
Zai Lab (ZLAB) China $12.382B 0.00
QIAGEN (QGEN) Netherlands $11.183B 22.84
Repligen (RGEN) United States $10.947B 120.40
Mirati Therapeutics (MRTX) United States $9.565B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.982B 0.00
Ultragenyx Pharmaceutical (RARE) United States $8.389B 0.00
Fate Therapeutics (FATE) United States $8.299B 0.00
Ascendis Pharma (ASND) Denmark $8.167B 0.00
Acceleron Pharma (XLRN) United States $7.888B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.593B 0.00
Denali Therapeutics (DNLI) United States $7.424B 236.00
Adaptive Biotechnologies (ADPT) United States $6.983B 0.00
Sarepta Therapeutics (SRPT) United States $6.918B 0.00
Exelixis (EXEL) United States $6.655B 60.94
Twist Bioscience (TWST) United States $6.324B 0.00
Halozyme Therapeutics (HALO) United States $5.672B 46.59
NeoGenomics (NEO) United States $5.663B 691.86
Blueprint Medicines (BPMC) United States $5.391B 17.75
Galapagos (GLPG) Belgium $5.385B 0.00
Vir Biotechnology (VIR) United States $5.341B 0.00
Certara (CERT) United States $5.188B 0.00
Emergent Biosolutions (EBS) United States $5.049B 12.07
SWEDISH ORP BIO (BIOVF) Sweden $4.950B 15.57
Biohaven Pharmaceutical Holding (BHVN) United States $4.907B 0.00
Beam Therapeutics (BEAM) United States $4.855B 0.00
China Biologic Products (CBPO) China $4.645B 30.10
Reata Pharmaceuticals (RETA) United States $4.430B 0.00
Arena Pharmaceuticals (ARNA) United States $4.420B 0.00
I-Mab (IMAB) China $4.405B 0.00
Intellia Therapeutics (NTLA) United States $3.908B 0.00
Insmed (INSM) United States $3.906B 0.00
Berkeley Lights (BLI) United States $3.784B 0.00
Arvinas (ARVN) United States $3.713B 0.00
SpringWorks Therapeutics (SWTX) United States $3.660B 0.00
Apellis Pharmaceuticals (APLS) United States $3.659B 0.00
Legend Biotech (LEGN) United States $3.404B 0.00
MorphoSys AG (MOR) Germany $3.256B 117.86
Alkermes (ALKS) Ireland $2.968B 0.00
Viela Bio (VIE) United States $2.911B 0.00
Editas Medicine (EDIT) United States $2.905B 0.00
NantKwest (NK) United States $2.897B 0.00
Amicus Therapeutics (FOLD) United States $2.818B 0.00
Intra-Cellular Therapies (ITCI) United States $2.666B 0.00
Global Blood Therapeutics (GBT) United States $2.630B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.553B 0.00
Sorrento Therapeutics (SRNE) United States $2.547B 0.00
Ligand Pharmaceuticals (LGND) United States $2.455B 46.47
Arcus Biosciences (RCUS) United States $2.449B 0.00
Morphic Holding (MORF) United States $2.320B 0.00
PHARMA MAR SA (PHMMF) Spain $2.312B 0.00
Amarin (AMRN) Ireland $2.267B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.213B 0.00
Genetron Holdings (GTH) China $2.200B 0.00
Myriad Genetics (MYGN) United States $2.163B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.987B 16.45
Inovio Pharmaceuticals (INO) United States $1.985B 0.00
Bluebird Bio (BLUE) United States $1.970B 0.00
NGM Biopharmaceuticals (NGM) United States $1.957B 0.00
Vericel (VCEL) United States $1.935B 842.00
Pandion Therapeutics (PAND) United States $1.819B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.751B 0.00
Scholar Rock Holding (SRRK) United States $1.732B 0.00
Precigen (PGEN) United States $1.730B 0.00
REGENXBIO (RGNX) United States $1.706B 0.00
Heska (HSKA) United States $1.704B 0.00
Seres Therapeutics (MCRB) United States $1.611B 0.00
Sangamo Therapeutics (SGMO) United States $1.604B 0.00
Zymeworks (ZYME) Canada $1.576B 0.00
UniQure (QURE) Netherlands $1.564B 0.00
Frequency Therapeutics (FREQ) United States $1.526B 0.00
Antibe Therapeutics (ATBPF) Canada $1.521B 0.00
Castle Biosciences (CSTL) United States $1.496B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.492B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.466B 0.00
Travere Therapeutics (TVTX) United States $1.399B 0.00
Zealand Pharma (ZEAL) Denmark $1.391B 0.00
Codexis (CDXS) United States $1.343B 0.00
Cytokinetics (CYTK) United States $1.338B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.330B 0.00
Bionano Genomics (BNGO) United States $1.310B 0.00
Alector (ALEC) United States $1.306B 0.00
Pliant Therapeutics (PLRX) United States $1.277B 0.00
Nurix Therapeutics (NRIX) United States $1.270B 0.00
Mersana Therapeutics (MRSN) United States $1.265B 0.00
MiMedx (MDXG) United States $1.253B 0.00
Northwest Biotherapeutics (NWBO) United States $1.238B 0.00
Avid Bioservices (CDMO) United States $1.234B 0.00
Zealand Pharma (ZLDPF) Denmark $1.203B 0.00
Coherus BioSciences (CHRS) United States $1.123B 9.13
Protagonist Therapeutics (PTGX) United States $1.123B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.115B 0.00
Adverum Biotechnologies (ADVM) United States $1.105B 0.00
Mesoblast (MESO) Australia $1.075B 0.00
Celldex Therapeutics (CLDX) United States $1.049B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $1.005B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.982B 41.59
Dynavax Technologies (DVAX) United States $0.962B 0.00
Cara Therapeutics (CARA) United States $0.944B 236.63
Epizyme (EPZM) United States $0.943B 0.00
G1 THERAPEUTICS (GTHX) United States $0.916B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.907B 0.00
MannKind (MNKD) United States $0.895B 0.00
Prothena (PRTA) Ireland $0.876B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.870B 0.00
Cellectis S.A (CLLS) France $0.856B 0.00
Sutro Biopharma (STRO) United States $0.820B 0.00
Pharming Group (PHGUF) Netherlands $0.814B 21.67
Adaptimmune Therapeutics (ADAP) United Kingdom $0.813B 0.00
Five Prime Therapeutics (FPRX) United States $0.809B 0.00
Kadmon Holdings (KDMN) United States $0.787B 0.00
AnaptysBio (ANAB) United States $0.785B 0.00
VBI Vaccines (VBIV) United States $0.746B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.738B 0.00
Merus (MRUS) Netherlands $0.731B 0.00
Cel-Sci (CVM) United States $0.730B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.716B 0.00
ChromaDex (CDXC) United States $0.705B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.685B 0.00
Starpharma Holdings (SPHRY) Australia $0.670B 0.00
ALBIREO PHARMA (ALBO) United States $0.659B 0.00
Agenus (AGEN) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Compugen (CGEN) Israel $0.610B 0.00
Precision BioSciences (DTIL) United States $0.596B 0.00
DBV Technologies S.A (DBVT) France $0.593B 0.00
Clovis Oncology (CLVS) United States $0.580B 0.00
Curis (CRIS) United States $0.571B 0.00
Anika Therapeutics (ANIK) United States $0.550B 74.42
MeiraGTx Holdings (MGTX) United States $0.547B 0.00
Geron (GERN) United States $0.528B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
AC Immune SA (ACIU) Switzerland $0.526B 0.00
Gritstone Oncology (GRTS) United States $0.523B 0.00
Amryt Pharma (AMYT) United Kingdom $0.517B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.511B 0.00
WAVE Life Sciences (WVE) Singapore $0.499B 0.00
Affimed (AFMD) Germany $0.495B 0.00
AMMO (POWW) United States $0.492B 0.00
Neoleukin Therapeutics (NLTX) United States $0.491B 0.00
Spero Therapeutics (SPRO) United States $0.471B 0.00
Syros Pharmaceuticals (SYRS) United States $0.468B 0.00
Kala Pharmaceuticals (KALA) United States $0.464B 0.00
AquaBounty Technologies (AQB) United States $0.459B 0.00
Athenex (ATNX) United States $0.450B 0.00
Selecta Biosciences (SELB) United States $0.436B 0.00
Fortress Biotech (FBIO) United States $0.431B 0.00
UROGEN PHARMA (URGN) United States $0.427B 0.00
Opthea (OPT) Australia $0.422B 0.00
Puma Biotechnology (PBYI) United States $0.416B 0.00
BioDelivery Sciences (BDSI) United States $0.411B 19.33
XOMA (XOMA) United States $0.398B 0.00
Verastem (VSTM) United States $0.387B 0.00
CytomX Therapeutics (CTMX) United States $0.380B 0.00
Cue Biopharma (CUE) United States $0.377B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.375B 0.00
Cardiff Oncology (CRDF) United States $0.375B 0.00
Forte Biosciences (FBRX) United States $0.374B 0.00
Athersys (ATHX) United States $0.372B 0.00
ANI Pharmaceuticals (ANIP) United States $0.361B 9.19
Kaleido Biosciences (KLDO) $0.353B 0.00
Oncobiologics (OTLK) United States $0.349B 0.00
Innate Pharma S.A (IPHA) France $0.347B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.342B 0.00
IBio (IBIO) United States $0.341B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.335B 0.00
Trevena (TRVN) United States $0.328B 0.00
Bellus Health (BLU) Canada $0.327B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.325B 0.00
NextCure (NXTC) United States $0.318B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.317B 0.00
Arbutus Biopharma (ABUS) United States $0.309B 0.00
Theratechnologies (THTX) Canada $0.308B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.293B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
Kamada (KMDA) Israel $0.279B 16.05
HOOKIPA Pharma (HOOK) United States $0.262B 0.00
Cerecor (CERC) United States $0.258B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.243B 0.00
TELA Bio (TELA) United States $0.241B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.240B 0.00
Applied Genetic Technologies (AGTC) United States $0.231B 0.00
OSMOTICA PHARM (OSMT) United States $0.226B 0.00
ADMA Biologics Inc (ADMA) United States $0.222B 0.00
Aptinyx (APTX) United States $0.222B 0.00
CorMedix Inc (CRMD) United States $0.220B 0.00
Abeona Therapeutics (ABEO) United States $0.216B 0.00
Checkpoint Therapeutics (CKPT) United States $0.215B 0.00
Voyager Therapeutics (VYGR) United States $0.209B 5.83
Idera Pharmaceuticals (IDRA) United States $0.204B 0.00
Eton Pharmaceuticals (ETON) United States $0.198B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Exicure (XCUR) United States $0.195B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.195B 0.00
GENFIT S.A (GNFT) France $0.194B 0.00
Strongbridge Biopharma (SBBP) United States $0.193B 0.00
VolitionRX (VNRX) United States $0.189B 0.00
VTv Therapeutics (VTVT) United States $0.180B 0.00
Nicox SA (NICXF) France $0.177B 0.00
Palatin Technologies (PTN) United States $0.176B 0.00
Pluristem Therapeutics (PSTI) Israel $0.176B 0.00
Kindred Biosciences (KIN) United States $0.176B 0.00
Orgenesis (ORGS) United States $0.173B 357.50
Protalix BioTherapeutics (PLX) Israel $0.170B 0.00
DiaMedica Therapeutics (DMAC) United States $0.169B 0.00
Clearside Biomedical (CLSD) United States $0.166B 0.00
Cogent Biosciences (COGT) United States $0.158B 0.00
Seelos Therapeutics (SEEL) United States $0.158B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.151B 0.00
Biofrontera AG (BFRA) Germany $0.151B 0.00
Aptevo Therapeutics (APVO) United States $0.149B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.148B 0.00
Dyadic (DYAI) United States $0.141B 0.00
Cyclerion Therapeutics (CYCN) United States $0.140B 0.00
Catalyst Biosciences (CBIO) United States $0.138B 0.00
Liminal BioSciences (LMNL) Canada $0.138B 0.00
Enzo Biochem (ENZ) United States $0.137B 0.00
Aytu Bioscience (AYTU) United States $0.137B 0.00
Evogene (EVGN) Israel $0.136B 0.00
Synlogic (SYBX) United States $0.134B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.130B 0.00
TRACON Pharmaceuticals (TCON) United States $0.129B 0.00
Prima BioMed (IMMP) Australia $0.127B 0.00
Liquidia Technologies (LQDA) United States $0.122B 0.00
CytRx (CYTR) United States $0.122B 0.00
Beyond Air (XAIR) United States $0.121B 0.00
Lumos Pharma (LUMO) United States $0.118B 0.00
PHASEBIO PHARMA (PHAS) United States $0.110B 0.00
Ecology Coatings (ABVC) United States $0.110B 0.00
ARAVIVE, INC (ARAV) United States $0.107B 0.00
Cidara Therapeutics (CDTX) United States $0.107B 0.00
Celyad SA (CYAD) Belgium $0.106B 0.00
Cocrystal Pharma (COCP) United States $0.105B 0.00
AIkido Pharma (AIKI) United States $0.095B 0.00
Novogen (KZIA) Australia $0.094B 0.00
Adocia (ADOCY) France $0.092B 0.00
Stealth BioTherapeutics (MITO) United States $0.091B 41.25
Vascular Biogenics (VBLT) Israel $0.088B 0.00
Advaxis (ADXS) United States $0.086B 0.00
Organovo Holdings (ONVO) United States $0.083B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.080B 0.00
Cleveland BioLabs (CBLI) United States $0.079B 0.00
AEterna Zentaris (AEZS) United States $0.077B 0.00
Celsion (CLSN) United States $0.076B 0.00
Vaccinex (VCNX) United States $0.075B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.073B 0.00
Windtree Therapeutics (WINT) United States $0.073B 0.00
Edesa Biotech (EDSA) Canada $0.072B 0.00
Purple Biotech (PPBT) Israel $0.070B 0.00
AnPac Bio-Medical Science (ANPC) China $0.070B 0.00
Emmaus Life Sciences (EMMA) United States $0.070B 0.00
Genetic Technologies (GENE) Australia $0.068B 0.00
Viracta Therapeutics (VIRX) United States $0.066B 0.00
ZIVO Bioscience (ZIVO) United States $0.063B 0.00
ARIDIS PHARMACT (ARDS) United States $0.062B 0.00
Pulmatrix (PULM) United States $0.057B 0.00
Appili Therapeutics (APLIF) Canada $0.052B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Happiness Biotech Group (HAPP) China $0.051B 0.00
Acorda Therapeutics (ACOR) United States $0.050B 0.00
Enveric Biosciences (ENVB) United States $0.049B 0.00
BioCardia (BCDA) United States $0.047B 0.00
Yumanity Therapeutics (YMTX) United States $0.046B 0.00
ATyr Pharma (LIFE) United States $0.044B 0.00
Alimera Sciences (ALIM) United States $0.042B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.040B 0.00
Prana Biotechnology (ATHE) Australia $0.037B 0.00
IMMURON (IMRN) Australia $0.037B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.033B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.031B 0.00
Lexaria Bioscience (LEXX) Canada $0.031B 0.00
Timber Pharmaceuticals (TMBR) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Seneca Biopharma (SNCA) United States $0.022B 0.00
GeoVax Labs (GOVX) United States $0.021B 0.00
ThermoGenesis Holdings (THMO) United States $0.021B 0.00
Invo BioScience (INVO) United States $0.017B 0.00
Benitec Biopharma (BNTC) United States $0.014B 0.00
Cyclo Therapeutics (CYTH) United States $0.014B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00